FDA Application
-
NDC Search Results on Active Ingredient: Cyclosporin
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| CYCLOSPORINE | 0023-5301-05 | Allergan, Inc. | NDA050790 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0023-5301-08 | Allergan, Inc. | NDA050790 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0023-9163-12 | Allergan, Inc. | NDA050790 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0023-9163-30 | Allergan, Inc. | NDA050790 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0023-9163-60 | Allergan, Inc. | NDA050790 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0061-1088-01 | Merck Sharp & Dohme Corp. | NADA141052 | PRESCRIPTION ANIMAL DRUG | NADA |
| CYCLOSPORINE | 0074-3108-32 | AbbVie Inc. | ANDA065003 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0074-3109-32 | AbbVie Inc. | ANDA065003 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0074-7269-50 | AbbVie Inc. | ANDA065025 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0078-0109-01 | Novartis Pharmaceuticals Corporation | NDA050573 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0109-61 | Novartis Pharmaceuticals Corporation | NDA050573 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0110-22 | Novartis Pharmaceuticals Corporation | NDA050574 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0240-15 | Novartis Pharmaceuticals Corporation | NDA050625 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0240-61 | Novartis Pharmaceuticals Corporation | NDA050625 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0241-15 | Novartis Pharmaceuticals Corporation | NDA050625 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0241-61 | Novartis Pharmaceuticals Corporation | NDA050625 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0246-15 | Novartis Pharmaceuticals Corporation | NDA050715 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0246-61 | Novartis Pharmaceuticals Corporation | NDA050715 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0248-15 | Novartis Pharmaceuticals Corporation | NDA050715 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0248-61 | Novartis Pharmaceuticals Corporation | NDA050715 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0078-0274-22 | Novartis Pharmaceuticals Corporation | NDA050716 | HUMAN PRESCRIPTION DRUG | NDA |
| CYCLOSPORINE | 0093-9018-19 | Teva Pharmaceuticals USA, Inc. | ANDA065110 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0093-9018-65 | Teva Pharmaceuticals USA, Inc. | ANDA065110 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0093-9019-19 | Teva Pharmaceuticals USA, Inc. | ANDA065110 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0093-9019-65 | Teva Pharmaceuticals USA, Inc. | ANDA065110 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0093-9020-19 | Teva Pharmaceuticals USA, Inc. | ANDA065110 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0093-9020-65 | Teva Pharmaceuticals USA, Inc. | ANDA065110 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0172-7313-20 | Teva Pharmaceuticals USA, Inc. | ANDA065078 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0378-8760-58 | Mylan Pharmaceuticals Inc. | ANDA205894 | HUMAN PRESCRIPTION DRUG | ANDA |
| CYCLOSPORINE | 0378-8760-91 | Mylan Pharmaceuticals Inc. | ANDA205894 | HUMAN PRESCRIPTION DRUG | ANDA |
| 1-30 | 31-60 | 61-90 | 91-97 |
-
